Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2+ metastatic breast cancer

Mohammad Jahanzeb, Joanne E. Mortimer, Furhan Yunus, David H. Irwin, James Speyer, Alan J. Koletsky, Paula Klein, Tariq Sabir, Lori Kronish

Research output: Contribution to journalArticlepeer-review

130 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2<sup>+</sup> metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences